Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy Fleischmann

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Expert Opinion on Biological Therapy|May 28, 2010
The efficacy and safety of golimumab in the treatment of arthritisRoy Fleischmann
Nature Clinical Practice. Rheumatology|March 31, 2007
Primer: establishing a clinical trial unit - regulations and infrastructureRoy Fleischmann
Arthritis Care & Research|February 1, 2020
2019 update of the American College of Rheumatology- recommended rheumatoid arthritis disease activity measures: comment on the article by England et alRoy Fleischmann
Rheumatology and Therapy|December 12, 2019
Looking Back on 2019 in Rheumatology and What to Expect from 2020Roy Fleischmann
Immunotherapy|October 19, 2017
Tofacitinib in the treatment of active rheumatoid arthritis in adultsRoy Fleischmann
Arthritis & Rheumatology (Hoboken, N.J.)|July 18, 2023
Is There a Role for Vagal Nerve Stimulation in the Treatment of Rheumatoid Arthritis?Roy Fleischmann
Rheumatology (Oxford, England)|February 23, 2011
Don't forget traditional DMARDsRoy Fleischmann
Rheumatology (Oxford, England)|February 21, 2025
Have we found a true disease-modifying osteoarthritis drug (DMOAD) or is there still much work to be done?Roy Fleischmann
Rheumatology (Oxford, England)|April 27, 2013
Back to the future: oral small molecule kinasesRoy Fleischmann
The Journal of Rheumatology|September 18, 2002
In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritisRoy Fleischmann
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Expert Opinion on Biological Therapy|May 28, 2010
The efficacy and safety of golimumab in the treatment of arthritisRoy Fleischmann
Nature Clinical Practice. Rheumatology|March 31, 2007
Primer: establishing a clinical trial unit - regulations and infrastructureRoy Fleischmann
Arthritis Care & Research|February 1, 2020
2019 update of the American College of Rheumatology- recommended rheumatoid arthritis disease activity measures: comment on the article by England et alRoy Fleischmann
Rheumatology and Therapy|December 12, 2019
Looking Back on 2019 in Rheumatology and What to Expect from 2020Roy Fleischmann
Immunotherapy|October 19, 2017
Tofacitinib in the treatment of active rheumatoid arthritis in adultsRoy Fleischmann
Arthritis & Rheumatology (Hoboken, N.J.)|July 18, 2023
Is There a Role for Vagal Nerve Stimulation in the Treatment of Rheumatoid Arthritis?Roy Fleischmann
Rheumatology (Oxford, England)|February 23, 2011
Don't forget traditional DMARDsRoy Fleischmann
Rheumatology (Oxford, England)|February 21, 2025
Have we found a true disease-modifying osteoarthritis drug (DMOAD) or is there still much work to be done?Roy Fleischmann
Rheumatology (Oxford, England)|April 27, 2013
Back to the future: oral small molecule kinasesRoy Fleischmann
The Journal of Rheumatology|September 18, 2002
In quest of the Holy Grail: efficacy versus effectiveness in rheumatoid arthritisRoy Fleischmann
Pageof 19